Boston Scientific Corp. is purchasing Axonics in a move the buyer says will allow it to pursue a ripe segment of the urology market. 

A pharmacy benefit management company founded less than five years ago is teaming up with a drug pricing disrupter that will mark its second birthday next month.

Over the past three years, the value of claims waiting longer than 90 days for payment from commercial payers has risen by 33%. Stalled Medicare Advantage claims have spiked by even more.

In its annual outlook report released this week, Fitch Ratings says the coming calendar year will probably strike much of the sector as “another make or break” period.

If the country avoids slipping into an economic recession over the next few months or even years, it could have the healthcare job market to thank.

Seeking to uncover the rationale driving hospitals to flout compliance, researchers interviewed hospital informants at 12 nonprofit institutions.

Televisits will cost $9 a month or $99 per year and are facilitated by One Medical. 

ChatGPT can be a little sneaky. Recently asked if it’s ever messed up when helping physicians make clinical decisions, it only came clean with examples of stumbles after being pressed on the matter.